Beyondspring Inc (BYSI)

May 23, 2025

Neutropenia Drugs Market Revenue to Surpass USD 24.2 Billion by 2033 with 4.7% CAGR - openPR.com

May 23, 2025

May 22, 2025

BeyondSpring Reports Q1 2025 Financials and Clinical Progress - TipRanks

May 22, 2025

May 17, 2025

BeyondSpring (NASDAQ:BYSI) Posts Earnings Results - MarketBeat

May 17, 2025

May 15, 2025

Can BeyondSpring (NASDAQ:BYSI) Afford To Invest In Growth? - Yahoo Finance

May 15, 2025

May 13, 2025

BeyondSpring Inc. (BYSI) Reports Q1 Loss of $0.08 - StreetInsider

May 13, 2025

May 12, 2025

BeyondSpring Reports First?Quarter 2025 Financial Results and Provides Corporate Update | BYSI Stock News - GuruFocus

May 12, 2025

May 12, 2025

BeyondSpring Inc. Reports Positive Early Results for Plinabulin in Metastatic Cancer and Updates on SEED Therapeutics' Progress - Nasdaq

May 12, 2025

May 12, 2025

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 12, 2025

May 08, 2025

BeyondSpring, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

May 08, 2025

May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025

Apr 29, 2025

SEED Therapeutics Secures FDA Rare Pediatric and Orphan Drug Designations for ST-01156 - MSN

Apr 29, 2025

Apr 10, 2025

BeyondSpring (NASDAQ:BYSI) Shares Pass Below 50 Day Moving AverageTime to Sell? - MarketBeat

Apr 10, 2025

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

BeyondSpring stock hits 52-week low at $1.34 amid market challenges - Investing.com India

Apr 04, 2025

Mar 30, 2025

BeyondSpring (NASDAQ:BYSI) Trading Down 3.8%Here's Why - MarketBeat

Mar 30, 2025

Mar 29, 2025

BeyondSpring’s 2024 Progress and Strategic Milestones - TipRanks

Mar 29, 2025

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

BeyondSpring stock hits 52-week low at $1.4 amid sharp decline - Investing.com

Mar 28, 2025

Mar 27, 2025

BeyondSpring Inc. (BYSI) reports earnings - Quartz

Mar 27, 2025

Mar 27, 2025

BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones - The Manila Times

Mar 27, 2025

Mar 27, 2025

BeyondSpring Files 2024 Annual Report on Form 10-K - GlobeNewswire

Mar 27, 2025

Mar 25, 2025

Global Febrile Neutropenia Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And - EIN News

Mar 25, 2025

Mar 25, 2025

In-Depth Analysis Of The Global Febrile Neutropenia Market Advancements Highlighted by Key Drivers, Trends,... - WhaTech

Mar 25, 2025

Mar 25, 2025

BeyondSpring's PlinabulinA Pipeline In Itself? - RTTNews

Mar 25, 2025

Mar 19, 2025

Molecular Glues Market to Register Stunning Growth During the Forecast Period (2025-2034) | DelveInsight - The Malaysian Reserve

Mar 19, 2025

Mar 09, 2025

BeyondSpring, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025

Mar 04, 2025

Pliant Therapeutics stock tumbles amid IPF trial cancellation - Clinical Trials Arena

Mar 04, 2025

Feb 25, 2025

BeyondSpring finalizes significant asset sale By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

BeyondSpring finalizes significant asset sale - Investing.com India

Feb 25, 2025

Feb 24, 2025

BeyondSpring (NASDAQ:BYSI) Stock Price Up 0.6%Time to Buy? - MarketBeat

Feb 24, 2025

Feb 17, 2025

Cancer Vaccines Market on Track for Major Expansion in - One News Page

Feb 17, 2025

Feb 12, 2025

Cancer Index takes hit in 2024 amid regulatory setbacks, failures - BioWorld Online

Feb 12, 2025

Feb 05, 2025

Deal Watch: Novo Nordisk, IMMvention To Partner On Sickle Cell Disease - Citeline News & Insights

Feb 05, 2025

Jan 31, 2025

BeyondSpring Inc. Enters into Preferred Share Purchase Agreement with SEED Therapeutics Inc. - Defense World

Jan 31, 2025